Clinical trial

Efficacy and Tolerability of Human FSH Versus Recombinant FSH (Follitropin…

NCT00335725 · IBSA Institut Biochimique SA, Industry · Completed

Key facts

NCT number NCT00335725
Title Efficacy and Tolerability of Human FSH Versus Recombinant FSH (Follitropin Alpha) in ICSI.
Official title Multicentric Prospective, Randomised, Controlled Clinical Study on Clinical Efficacy and Tolerability of Urinary FSH (Fostimon® , IBSA) Versus r-FSH (Gonal-F®, Serono) in ICSI.
Lead sponsor IBSA Institut Biochimique SA, Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Infertility
Intervention type Drug
Interventions Follicle Stimulating Hormone
Enrollment 151
Start date Mar 1, 2003
Primary completion Dec 1, 2005
Completion Dec 1, 2005
First posted Jun 12, 2006
Last update posted Mar 27, 2015
Countries France, Hungary

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies